S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

LAMVIN Launches Sonic Theater Board for On-Site Acoustic Customization

A standard utility knife is all contractors need to install LAMVIN’s new Sonic Theater Board, a rigid, black sound-absorptive panel designed to mitigate reverberation in commercial and educational spaces. The product aims to streamline the renovation process by allowing for precise, field-adjusted sizing to fit nearly any ceiling grid configuration.

LAMVIN Launches Sonic Theater Board for On-Site Acoustic Customization
Photo: Bio & News

These lightweight panels arrive in standard 4-by-8-foot boards or pre-cut 2-by-2 and 2-by-4-foot tiles. Available in two density options—3 lb. and 6 lb.—and two thicknesses, the boards provide architects and designers with the versatility to address specific acoustic requirements across hospitality, performance venues, and office environments. Every unit carries a Class A fire rating under ASTM E84 standards.

Installation remains adaptable, supporting various mounting hardware including Z-Clips, L-Brackets, and Rotofast snap-on anchors. According to David Castellanos, VP of Sales and Business Development at LAMVIN, the goal is to provide a functional solution that simplifies the workflow for contractors. As speech intelligibility and occupant comfort become primary design drivers, these boards offer a practical way to manage noise in high-traffic public areas without the need for specialized cutting equipment or complex off-site fabrication.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!